The document provides information about Dr. Anand Burman, the chairman of Dabur India Limited. It discusses his educational background and career journey. After earning a PhD in pharmaceutical chemistry from the University of Kansas, he joined Dabur in 1980. Under his leadership, Dabur has grown significantly from revenues of Rs. 20 crores to over Rs. 100 crores. His focus on research and development in biotechnology and attracting talented professionals helped professionalize the company and fuel its growth. Today Dabur generates over $1.2 billion in annual revenues and remains majority owned by the Burman family.

1. www.csrajivbajaj.com
c
THOUGHT OF THE DAY
“Start by doing what's necessary; then do what's possible;
and suddenly you are doing the impossible...”
Law Updates:
 Vide General Circular No-06/2015 dated 09.04.2015, MCA clarified
that Investment in tax-free bonds yielding higher return than Govt.
security isn't violation of loan & Investment norms.
 Vide RBI Notification ref RBI/2014-15/551 DNBR (PD).CC.No.028
/03.10.001/2014-15 dated April 10, 2015, RBI has issued Revised
norms for NBFCs Lending against Shares. New rules to make
NBFCs more accountable. The central bank intends to prescribe
norms as NBFCs outsourcing various activities are exposed to
various risks.
 FM Arun Jaitley hinted at further reform of the tax structure to
make it internationally compatible and non-adversarial for IFSC.
 Sahoo panel bats for lifting caps on ECBs. Recommends lifting all
sectoral caps, end-use restriction but insists on firms hedging at
least a specified proportion
PROFESSIONALS INPUTS:
 MCA has issued The Companies (Auditor’s Report) Order, 2015
dated 10th April, 2015, whereby New CARO, 2015 excludes One
Person Co, small Co and Pvt Cos having outstanding loan of less
than Rs 25 lakhs.
 SEBI has issued SEBI (Public Offer and Listing of Securitised Debt
Instruments) (Amendment) Regulations, 2015 dated April 9,2015
whereby SEBI stipulates net worth of 2 crores for applicants seeking
to act as trustees of Securitized debt instruments.
 General Circular No, 07l2015 dated 10th April, 2015 issued by MCA
providing clarificatlon with regard to payment for period remaining
for Remureration to managerlal person under Schedule XIII of the
Companies Act, 1956 and it is clarified that managerial personnel
referred above may continue to receive remuneration for remaining
period in accordance with the provisions of old act even if his tenure
falls after 1st April, 2014.
MARKET WATCH:
SENSEX: 28879.38 -5.83 NIFTY:8780.35 2.05
SILVER:36735.00 452.00 GOLD (MCX): 26795.00 274.00
USD/INR: 62.31 0.06 CRUDE OIL: 3217.00 2.00
CS Rajiv Bajaj
9811453353
Bajajr66@gmail.com
youtube.com/csrajivbajaj
https://www.facebook.com/Rajiv
1Bajaj
http://www.csrajivbajaj.com
Date: 11th April, 2015

2. www.csrajivbajaj.com
Dr. Anand Burman,
Dabur India Limited
A buoyant consumer market lifted Anand Burman's fortune thanks to
his family's two-thirds stake in Dabur, which reported net earnings of
$152 million on $1.2 billion revenues in the last year. Its portfolio of
400 products includes honey, hair oil and fruit juices. Family also has
stakes in insurance, real estate and sports. Property arm, the quaintly
named Elephant London, is building residences in London's Battersea
area. The Burmans also co-own an upcoming tech park in Gurgaon,
near Delhi.
BRIEF PROFILE-
Dr. Anand Burman joined the Dabur family in the year 1980, after
earning a PhD degree in Pharmaceutical Chemistry from the prestigious University of Kansas. Also,
he earned his bachelor’s degree from the University of Wisconsin, USA; followed by a M.Sc. degree
from the University of Kansas. Further, Dr. Anand completed his schooling from the glorious St.
Paul’s School in Darjeeling.
BUSINESS JOURNEY
Dr. Anand Burman is currently the chairman of the 127 year old consumer goods maker, Dabur. Being
the India’s largest Ayurvedic medicine manufacturer, Dabur crossed the billion dollar mark in 2012
under the flagship of Dr. Burman. Founded in the year 1884 by a Bengali Physician, Dr. SK Burman,
the chunk of company share continues to belong to the family, which even today owns nearly two
thirds of the consumer goods firm.
Dr. Anand’s keen interest in Research and Development in the field of Biotechnology and
Pharmaceutical Sciences has been instrumental to the growth of the Dabur industry. Before the time
Dr. Anand had joined Dabur, it was generating revenue of nearly Rs. 20 crores, but after a decade; in
the 1990’s Dabur’s revenue had gone up to Rs. 100 crore.
Dr. Anand realised the enormous growth potential in the field of Ayurvedic medicine and keenly
studied the Indian consumer market. So, he devised strategies that would cater to the needs of the
Indian consumer in the best possible way.
LEADERSHIP QUALITY FACTOR:
Under the guidance of his uncle late G.C. Burman, Dr. Anand picked up the minute details of the
trade. He had two major strategies in mind for the growth of the company in future. First, he wished
to attract good talent to his company. So, made a sincere effort to recruit in some of the best and most
talented professionals of the field and was quite successful. Secondly, he wanted to avoid family
conflicts. So, he requested his family members to give up all the major executive positions in the
company to highly qualified professionals. Thus, by achieving these two motives, Dr. Anand brought
in a sense of ‘professionalism’ to the systems and processes of the company. From that moment
onwards there was no looking back. Hence, with in a short period of time, Dabur India Limited
emerged out as one of India’s biggest consumer brands.